Targeting Bcl-2 Proteins in Acute Myeloid LeukemiaYunxiong Wei, Mingfeng Zhao, Xia Xiong et al.|Frontiers in Oncology|2020Cited by 82
Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndromeYunxiong Wei, Mingfeng Zhao, Xin Jin et al.|Cancer Science|2021Cited by 71